Larnaca, Cyprus, 10-11 November 2015
The Council of Europe (CoE), in co-operation with both the Ministry of Justice and Public Order and the Ministry of Health of Cyprus, organised the fourth Regional Conference on the Council of Europe Convention on the counterfeiting of medical products and similar crimes involving threats to public health (MEDICRIME Convention) in Larnaca, Cyprus, on 10-11 November 2015.
The aim of the Conference was
- to encourage States to sign and ratify the Convention;
- to raise awareness among members of parliament, law enforcement agencies, NGOs, the media and professionals working in the field;
- to discuss the benefits and challenges in ratifying the Convention; and
- to exchange experiences, know-how and reinforce international co-operation.
Mr Andreas Mylonas, Permanent Secretary of the Ministry of Justice and Public Order, and Ms Popi Kanari, Director of the State General Laboratory of the Ministry of Health, addressed the participants and expressed the strong support of Cyprus towards the CoE’s efforts to combat the counterfeiting of medical products and similar crimes and announced that Cyprus intends to ratify the MEDICRIME Convention in the near future.
- "MEDICRIME Convention: background, origins and objectives" - Mr Hugo Bonar, Health Products Regulatory Authority, Ireland
- "Cyprus strategy against counterfeiting of medicinal products" - Ms Anna Paphitou, Ministry of Health, Cyprus
- "A customs approach to combat trafficking in counterfeiting of medicines" - Mr Genti Çani, World Customs Organization
- "The prosecution of the perpetrators: international experience and added value of EUROJUST" - Mr Francisco Jiménez-Villarejo, EUROJUST
- "The added value of the MEDICRIME Convention from the criminal law perspective" - Mr Asier Urruela Mora, University of Zaragoza, Spain
- "The role of Customs Authorities in the fight against counterfeiting of medical products" - Mr George Constantinou, Customs and Excise, Cyprus
- "The Importance of Networking – The Council of Europe SPOCs Model" - Ms Monika Macisowicz, Main Pharmaceutical Inspectorate, Poland
Disclaimer: The opinions expressed in the presentations are the responsibility of the authors and do not necessarily reflect the official policy of the Council of Europe.